DP, A., L, B., E, M., A, C., V, M., W, R., . . . EZ, P. (2026). Argonaute 2 drives resistance to immune checkpoint inhibitors in immunorefractory non-small cell lung cancer. PLoS biology, 24(6), e3003860. https://doi.org/10.1371/journal.pbio.3003860
Chicago Style (17th ed.) CitationDP, Anobile, et al. "Argonaute 2 Drives Resistance to Immune Checkpoint Inhibitors in Immunorefractory Non-small Cell Lung Cancer." PLoS Biology 24, no. 6 (2026): e3003860. https://doi.org/10.1371/journal.pbio.3003860.
MLA (9th ed.) CitationDP, Anobile, et al. "Argonaute 2 Drives Resistance to Immune Checkpoint Inhibitors in Immunorefractory Non-small Cell Lung Cancer." PLoS Biology, vol. 24, no. 6, 2026, p. e3003860, https://doi.org/10.1371/journal.pbio.3003860.
Warning: These citations may not always be 100% accurate.
